Table 2:

Clinical and Treatment Characteristics of Study Participants at Baseline

Treatment characteristics at Baseline	All (n=25)	(n=8)	Intervention (n=17)	p-value
Did you make treatment decision				1
Yes	22 (95.6%)	7 (100%)	15 (93.7%)
No	1 (4.4%)	0 (0%)	1 (6.3%)
What treatment are you leaning toward?				0.174
Ileal conduit	15 (68.2%)	3 (42.8%)	12 (70.6%)
Continent reservoir	1 (4.5%)	1 (14.4%)	3 (17.6%)
Neobladder	6 (27.3%)	3 (42.8%)	2 (11.8%)
Doctor’s treatment preference				0.325
Ileal conduit	14 (70%)	3 (50%)	11 (68.7%)
Continent reservoir	1 (5%)	1 (16.7%)	3 (18.7%)
Neobladder	5 (25%)	2 (33.3%)	1 (6.3%)
Are you insured?				1
Yes	25 (100%)	25 (100%)	25 (100%)
No	0 (0%)	0 (0%)	0 (0%)
How strong was treatment recommendation?				0.7713
Very strong	14 (58.3%)	4 (50%)	10 (62.5%)
Moderately strong	9 (37.5%)	4 (50%)	5 (31.3%)
Not very strong	0 (0%)	0 (0%)	0 (0%)
Not at all strong	1 (4.2%)	0 (0%)	1 (6.2%)
Number of comorbidities	2±2.2	1±1.7	2±2.5	0.8348

^*Categorical variables compared with fisher’s exact tests; Continuous variables compared with Mann-Whitney U Tests – Mean (Frequency) presented.

^*P-values in bold indicate statistical significance at the p<0.05 level